The recent decision to remove customs duty exemption on the imports of ~70 drugs could also have a significant economic impact. India’s pharmaceutical industry suffers from a significant lack of competition. India’s drug pricing regime remains ripe for change. We need to ensure affordability of life-saving drugs. We must encourage a centralised procurement system, as utilised by Tamil Nadu, for purchasing drugs. Unethical and unfair drug selling practices, such as holiday trip offers and fancy gifts, used to influence doctors and key bureaucrats, need to be curbed.
No comments:
Post a Comment